Natera · 3 months ago
Associate Medical Director - Gynecologic Cancer
United States
Full-time
Remote
Lead/Staff, Director/Executive
$171K/yr - $214K/yr
5+ years expNatera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. In this strategic leadership role, the Associate Medical Director will provide medical expertise for Natera's oncology portfolio, collaborating with various teams to ensure the scientific integrity and clinical adoption of oncology testing solutions.
BiotechnologyGeneticsHealth DiagnosticsMedicalWomen's
Responsibilities
Collaborate with the Sr. Medical Director, Oncology on the clinical development of ctDNA-based diagnostics
Lead development and implementation of clinical strategies for Natera's oncology products
Oversee medical education and scientific communication for healthcare providers on Natera's oncology offerings
Partner with the commercial team to develop and deliver compelling medical messages for Natera's oncology products
Represent Natera at medical conferences and industry events, in person and virtual
Foster a culture of scientific excellence and intellectual curiosity within the oncology team
Collaborate with research and development teams on clinical trial design, data analysis, and publication
Strong knowledge in Gynecologic Cancer, with the ability to develop and implement strategies specific to Gynecologic oncology
Provide expert guidance and support on Gynecologic oncology cases and clinical trials
Ability to speak to all histologies and indications, ensuring broad expertise across the oncology spectrum
Stay updated on the latest advancements in various cancer types and integrate this knowledge into Natera’s oncology products
Work effectively with cross-functional teams including research, development, commercial, and medical affairs to drive the success of oncology initiatives
Coordinate with internal and external stakeholders to ensure the clinical relevance and adoption of Natera’s oncology solutions
Qualification
Required
M.D. or D.O. degree with board certification in Oncology required
At least 5 years of experience in oncology, with a strong background in clinical research and development
At least 3 years of clinical trial experience in academia, biotech industry, or equivalent
Associate/full medical director designation commensurate with experience
Ability to quickly learn Natera's technology and that of our competitors, understanding the strengths and limitations of each, and articulate strong customer value propositions
Proven skill and experience in building and managing a team
Effective written and oral communication skills, with strong persuasive abilities and quick thinking
Project management skills, with the ability to balance and execute multiple projects simultaneously
Proven team player, capable of participating as a member of a cross-disciplinary team
Ability to manage conflict with poise
Preferred
Strong knowledge in endometrium cancer preferred
Strong knowledge of clinical trial methodology, protocol development, regulatory and compliance requirements, statistics, and epidemiology is preferred
Benefits
Comprehensive medical, dental, vision, life and disability plans for eligible employees and their dependents
Free testing in addition to fertility care benefits
Pregnancy and baby bonding leave
401k benefits
Commuter benefits
Generous employee referral program
Company
Natera
Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.
5001-10000 employees
H1B Sponsorship
Natera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (90)
2024 (72)
2023 (37)
2022 (71)
2021 (64)
2020 (40)
Funding
Current Stage
Public CompanyTotal Funding
$1.16BKey Investors
Sofinnova InvestmentsLightspeed Venture PartnersSequoia Capital
2023-09-07Post Ipo Equity· $250M
2022-11-15Post Ipo Equity· $400.05M
2022-03-16Post Ipo Equity· $5M
Leadership Team
Steve Chapman
CEO
Jonathan Sheena
Co-Founder, Board Member
Recent News
2026-01-22
Business Wire
2026-01-22
Company data provided by crunchbase